Gunjan Shah

64PUBLICATIONS
277CO-AUTHORS
Carbon capture engineering (excl. sequestration)Haematological tumoursPredictive and prognostic markersMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Oct 20, 2026
The EF1α promoter of cilta-cel drives a highly effective GZMK+ transcriptional program.

|Oct 02, 2026
Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jul 07, 2026
Concurrent administration of BCMA and GPRC5D CAR T cells for advanced multiple myeloma.

Pageof 11

Frequent Collaborators

36 joint publications

Sergio Giralt

25 joint publications

Heather Landau

23 joint publications

Urvi Shah

22 joint publications

Miguel-Angel Perales